These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 9759660)

  • 1. Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment.
    Takeda A; Hashimoto M; Mallory M; Sundsumo M; Hansen L; Sisk A; Masliah E
    Lab Invest; 1998 Sep; 78(9):1169-77. PubMed ID: 9759660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders.
    Takeda A; Mallory M; Sundsmo M; Honer W; Hansen L; Masliah E
    Am J Pathol; 1998 Feb; 152(2):367-72. PubMed ID: 9466562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
    Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy.
    Wakabayashi K; Hayashi S; Kakita A; Yamada M; Toyoshima Y; Yoshimoto M; Takahashi H
    Acta Neuropathol; 1998 Nov; 96(5):445-52. PubMed ID: 9829807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease.
    Wakabayashi K; Matsumoto K; Takayama K; Yoshimoto M; Takahashi H
    Neurosci Lett; 1997 Dec; 239(1):45-8. PubMed ID: 9547168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Widespread occurrence of alpha-synuclein/NACP-immunoreactive neuronal inclusions in juvenile and adult-onset Hallervorden-Spatz disease with Lewy bodies.
    Wakabayashi K; Yoshimoto M; Fukushima T; Koide R; Horikawa Y; Morita T; Takahashi H
    Neuropathol Appl Neurobiol; 1999 Oct; 25(5):363-8. PubMed ID: 10564525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-terminal alpha-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders.
    Takeda A; Hashimoto M; Mallory M; Sundsumo M; Hansen L; Masliah E
    Acta Neuropathol; 2000 Mar; 99(3):296-304. PubMed ID: 10663973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
    Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
    J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.
    Culvenor JG; McLean CA; Cutt S; Campbell BC; Maher F; Jäkälä P; Hartmann T; Beyreuther K; Masters CL; Li QX
    Am J Pathol; 1999 Oct; 155(4):1173-81. PubMed ID: 10514400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies.
    Arima K; Uéda K; Sunohara N; Hirai S; Izumiyama Y; Tonozuka-Uehara H; Kawai M
    Brain Res; 1998 Oct; 808(1):93-100. PubMed ID: 9795161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NACP/alpha-synuclein, NAC, and beta-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases.
    Yokota O; Terada S; Ishizu H; Ujike H; Ishihara T; Nakashima H; Yasuda M; Kitamura Y; Uéda K; Checler F; Kuroda S
    Acta Neuropathol; 2002 Dec; 104(6):637-48. PubMed ID: 12410385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
    Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC
    Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy.
    Shoji M; Harigaya Y; Sasaki A; Uéda K; Ishiguro K; Matsubara E; Watanabe M; Ikeda M; Kanai M; Tomidokoro Y; Shizuka M; Amari M; Kosaka K; Nakazato Y; Okamoto K; Hirai S
    J Neurol Neurosurg Psychiatry; 2000 May; 68(5):605-8. PubMed ID: 10766891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
    Bayer TA; Jäkälä P; Hartmann T; Havas L; McLean C; Culvenor JG; Li QX; Masters CL; Falkai P; Beyreuther K
    Neurosci Lett; 1999 May; 266(3):213-6. PubMed ID: 10465711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.
    Mattila PM; Rinne JO; Helenius H; Dickson DW; Röyttä M
    Acta Neuropathol; 2000 Sep; 100(3):285-90. PubMed ID: 10965798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of NACP/alpha-synuclein and its role in Alzheimer's disease.
    Iwai A
    Biochim Biophys Acta; 2000 Jul; 1502(1):95-109. PubMed ID: 10899435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC).
    Yokota O; Terada S; Ishizu H; Tsuchiya K; Kitamura Y; Ikeda K; Uéda K; Kuroda S
    Acta Neuropathol; 2002 Oct; 104(4):333-41. PubMed ID: 12200618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
    Baba M; Nakajo S; Tu PH; Tomita T; Nakaya K; Lee VM; Trojanowski JQ; Iwatsubo T
    Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
    Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW
    J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lewy body variant of Alzheimer's disease: alpha-synuclein in dystrophic neurites of A beta plaques.
    Wirths O; Weickert S; Majtenyi K; Havas L; Kahle PJ; Okochi M; Haass C; Multhaup G; Beyreuther K; Bayer TA
    Neuroreport; 2000 Nov; 11(17):3737-41. PubMed ID: 11117482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.